Orbimed to offload 2.27% stake in Marksans Pharma via ₹256.8 crore block deal

Shares of Marksans Pharma Ltd ended at ₹250.20, down by ₹2.90, or 1.15%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *